← HAEMONETICS CORP
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $886.1m | $903.9m | $967.6m | $988.5m | $870.5m | $993.2m | $1.2b | $1.3b | $1.4b | $1.3b | |
| Revenue from Contract with Customer, Including Assessed Tax | $886.1m | $903.9m | $967.6m | $988.5m | $870.5m | $993.2m | $1.2b | $1.3b | $1.4b | $1.3b | |
| Cost of Revenue | $507.6m | $492.0m | $550.0m | $504.0m | $472.6m | $487.7m | $553.6m | $617.5m | $611.9m | $546.4m | |
| Gross Profit | $378.5m | $411.9m | $417.5m | $484.5m | $397.8m | $505.5m | $615.1m | $691.5m | $749.0m | $787.6m | |
| Operating Expenses | $397.9m | $355.8m | $334.0m | $381.2m | $308.1m | $424.8m | $459.1m | $526.7m | $527.1m | $630.9m | |
| Operating Income (Loss) | ($19.4m) | $56.2m | $83.5m | $103.4m | $89.7m | $80.8m | $156.0m | $164.9m | $221.8m | $156.7m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $37.2m | $31.9m | $32.6m | $34.2m | $32.8m | $56.6m | $42.1m | $41.4m | $55.6m | $50.5m | |
| Capitalized Computer Software, Amortization | $9.5m | $4.4m | $12.5m | — | — | $8.4m | $8.5m | $8.6m | $6.7m | $6.1m | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($1.8m) | ($200k) | ($2.3m) | ($2.9m) | ($700k) | ($1.5m) | ($1.0m) | ($4.0m) | ($900k) | ($3.2m) | |
| Gain (Loss) on Investments | — | — | — | — | — | — | $0 | $0 | $0 | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | $1.4m | $5.2m | $6.7m | — | — | |
| Goodwill, Impairment Loss | $57.0m | — | $0 | $0 | — | — | — | $0 | $0 | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($44.7m) | $3.5m | $26.7m | $5.3m | $5.5m | ($5.2m) | $85.7m | $112.6m | $161.8m | $87.2m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | $63.6m | $141.4m | $151.9m | $212.1m | $128.0m | |
| Net Income (Loss) Attributable to Parent | ($26.3m) | $45.6m | $55.0m | $76.5m | $79.5m | $43.4m | $115.4m | $117.6m | $167.7m | $97.3m | |
| Earnings Per Share, Basic | ($0.51) | $0.86 | $1.07 | $1.51 | $1.57 | $0.85 | $2.27 | $2.32 | $3.33 | $2.06 | |
| Earnings Per Share, Diluted | ($0.51) | $0.85 | $1.04 | $1.48 | $1.55 | $0.84 | $2.24 | $2.29 | $3.31 | $2.05 | |
| Weighted Average Number of Shares Outstanding, Basic | 51.5m | 52.8m | 51.5m | 50.7m | 50.7m | 51.0m | 50.8m | 50.7m | 50.3m | 47.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | 51.5m | 53.5m | 52.9m | 51.8m | 51.3m | 51.4m | 51.4m | 51.4m | 50.7m | 47.4m | |
| Research and Development Expense | $37.6m | $39.2m | $35.7m | $30.9m | $32.9m | $46.8m | $50.1m | $54.4m | $62.7m | $59.8m | |
| Selling, General and Administrative Expense | $301.7m | $316.5m | $298.3m | $299.7m | $274.2m | $339.6m | $376.7m | $431.8m | $436.8m | $442.4m | |
| Other Nonoperating Income (Expense) | ($8.1m) | ($4.5m) | ($9.9m) | ($16.2m) | ($16.8m) | ($17.1m) | ($14.6m) | ($13.0m) | ($9.7m) | ($28.7m) | |
| Current Income Tax Expense (Benefit) | $5.6m | $19.9m | $5.3m | $17.4m | $14.3m | $15.2m | $20.2m | $45.2m | $50.0m | $57.1m | |
| Interest Expense, Debt | — | — | — | $13.5m | $9.4m | $5.8m | $13.0m | $19.5m | $35.9m | $19.3m | |
| Restructuring and Related Cost, Incurred Cost | — | — | — | $3.6m | $1.4m | — | — | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | — | $14.1m | — | — | |
| Income Tax Expense (Benefit) | ($1.2m) | $14.1m | $18.6m | $10.6m | ($6.6m) | $20.3m | $26.0m | $34.3m | $44.4m | $30.7m | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | ($289k) | — | — | — | — | $184k | $330k | $0 | $104k | ($15k) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.